AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt-MDM2-Foxo3a Signaling Axis

Podobne zapisy

• AMPK as a Potential Anticancer Target – Friend or Foe?
  od: Chuang, Hsiao-Ching, i wsp.
  Wydane: (2014)
• Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator
  od: Lee, Kuen-Haur, i wsp.
  Wydane: (2011)
• Vitamin E Facilitates the Inactivation of the Kinase Akt by the Phosphatase PHLPP1
  od: Huang, Po-Hsien, i wsp.
  Wydane: (2013)
• A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells
  od: Chou, Chih-Chien, i wsp.
  Wydane: (2015)
• Exploitation of the Ability of γ-Tocopherol to Facilitate Membrane Co-localization of Akt and PHLPP1 to Develop PHLPP1-Targeted Akt Inhibitors
  od: Yan, Ribai, i wsp.
  Wydane: (2015)